|
|
|
|
|
||||||||
|
Induction
Of Elevated Protective Immunity And Phagocytosis In The American LobsterWilliam.
D. Paterson1 and I. R. Keith2 1Paterson Applied Technology,
Loretto, Ontario, Canada; 2Charlottetown, Prince Edward Island,
Canada The valuable
commercial lobster fishery suffers significant annual losses due to disease,
especially during the pounded holding periods, characteristic of this
industry. Research progresses to
understand this phenomenon toward providing tools to minimize these losses. In this presentation, stimulated increases in
phagocytosis and protective immunity against gaffkemia will be described. Previously developed procedures to quantify
the in vitro phagocytosis of sheep erythrocytes (SRBC) and Aerococcus
viridans var homari bacteria by lobster hemocytes were utilized to
measure the effect of several stimulants on the level of phagocytosis. Stimulation of lobsters with Pseudomonas
perolens cells or endotoxin resulted in increased phagocytosis. A lower response was elicited by A.
viridans cellular vaccines. The
dynamics of this increased phagocytic response indicated an onset of eight days
and duration of about 80 days. Lack of
specificity was shown by increases in
phagocytosis of particles other than those of the stimulant source. The conference of increased protective
immunity against gaffkemia was evaluated in the laboratory using both juvenile
and adult lobsters and in the field with adult animals. A vaccine composed of inactivated A.
viridans cells was injected into the ventral sinus of each treated
animal. Protection was evaluated
following assessment of gaffkemia mortality caused by injection of graded doses
of virulent, viable A. viridans cells.
Significant increases in survival of both juvenile and adult animals
resulted following vaccination. The
increase in gaffkemia protection was detected about six days after vaccination
of lobsters and lasted for approximately 90 days. In the field, protective immunity to gaffkemia was assessed in
Bay of Fundy lobster pounds using differential banding to distinguish between
vaccinates and controls. Survival
recovery data constituted the measure of vaccine performance. In three trials using different lobster
stocks, vaccination increased susrvival by 12.5, 16.7, and 26.2 percent,
respectively. In summary, increased
phagocytosis and protective immunity resulted from stimulation or vaccination
of lobsters. Only virulent A.
viridans was a potent immunogen.
Return to 28th Annual Eastern Fish Health WorkshopReturn to Leetown Science Center Home Page |